Che Ma
16Patents
4h-index
22Co-inventors
56Inventor score
Filing activity: Jan 15, 2009 → May 13, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10023892B2 | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy | Emerging Cross-Sectional Technologies | 12 | Active |
| US10118969B2 | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy | Chemistry; Metallurgy | 11 | Active |
| US11866485B2 | Antibody specific to spike protein of SARS-CoV-2 and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US11918641B2 | Chimeric influenza vaccines | Chemistry; Metallurgy | 6 | Active |
| US8741311B2 | Methods and compositions for immunization against virus | Emerging Cross-Sectional Technologies | 4 | Active |
| US9403878B2 | Methods for producing virus particles with simplified glycosylation of surface proteins | Emerging Cross-Sectional Technologies | 3 | Active |
| US9920347B2 | Methods for producing virus particles with simplified glycosylation of surface proteins | Emerging Cross-Sectional Technologies | 2 | Active |
| US8916540B2 | Antibiotic compositions and related screening methods | Emerging Cross-Sectional Technologies | 1 | Active |
| US11992525B2 | Chimeric influenza vaccines | Chemistry; Metallurgy | 1 | Active |
| US10307475B2 | Methods and compositions for immunization against virus | Emerging Cross-Sectional Technologies | 1 | Active |
| US12178870B2 | Chimeric influenza vaccines | Chemistry; Metallurgy | 0 | Active |
| US12157763B2 | Antibody specific to spike protein of SARS-CoV-2 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12257298B2 | Coronavirus vaccine | Chemistry; Metallurgy | 0 | Active |
| US9890111B2 | Crystal structure of bifunctional transglycosylase PBP1b from E. coli and inhibitors thereof | Physics | 0 | Active |
| US11672853B2 | Methods and compositions for immunization against virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US10793628B2 | Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.